251 related articles for article (PubMed ID: 28739383)
1. Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects.
Sini C; Noris Chiorda B; Gabriele P; Sanguineti G; Morlino S; Badenchini F; Cante D; Carillo V; Gaetano M; Giandini T; Landoni V; Maggio A; Perna L; Petrucci E; Sacco V; Valdagni R; Rancati T; Fiorino C; Cozzarini C
Radiother Oncol; 2017 Aug; 124(2):296-301. PubMed ID: 28739383
[TBL] [Abstract][Full Text] [Related]
2. Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.
Bresolin A; Faiella A; Garibaldi E; Munoz F; Cante D; Vavassori V; Waskiewicz JM; Girelli G; Avuzzi B; Villa E; Magli A; Noris Chiorda B; Gatti M; Ferella L; Maggio A; Landoni V; Aimonetto S; Sini C; Rancati T; Sanguineti G; Valdagni R; Di Muzio N; Fiorino C; Cozzarini C
Radiother Oncol; 2021 May; 158():74-82. PubMed ID: 33639190
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer.
Fiorino C; Alongi F; Perna L; Broggi S; Cattaneo GM; Cozzarini C; Di Muzio N; Fazio F; Calandrino R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):29-35. PubMed ID: 19467803
[TBL] [Abstract][Full Text] [Related]
4. Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy.
Longobardi B; Berardi G; Fiorino C; Alongi F; Cozzarini C; Deli A; La Macchia M; Perna L; Di Muzio NG; Calandrino R
Radiother Oncol; 2011 Dec; 101(3):460-4. PubMed ID: 21864924
[TBL] [Abstract][Full Text] [Related]
5. Defining the "Hostile Pelvis" for Intensity Modulated Radiation Therapy: The Impact of Anatomic Variations in Pelvic Dimensions on Dose Delivered to Target Volumes and Organs at Risk in Patients With High-Risk Prostate Cancer Treated With Whole Pelvic Radiation Therapy.
Yirmibeşoğlu Erkal E; Karabey S; Karabey A; Hayran M; Erkal HŞ
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):894-903. PubMed ID: 26104941
[TBL] [Abstract][Full Text] [Related]
6. Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy?
Min M; Chua B; Guttner Y; Abraham N; Aherne NJ; Hoffmann M; McKay MJ; Shakespeare TP
Radiother Oncol; 2014 Feb; 110(2):278-83. PubMed ID: 24412017
[TBL] [Abstract][Full Text] [Related]
7. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity.
Fonteyne V; De Neve W; Villeirs G; De Wagter C; De Meerleer G
Radiother Oncol; 2007 Aug; 84(2):156-63. PubMed ID: 17692976
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effect.
Cozzarini C; Rancati T; Palorini F; Avuzzi B; Garibaldi E; Balestrini D; Cante D; Munoz F; Franco P; Girelli G; Sini C; Vavassori V; Valdagni R; Fiorino C
Radiother Oncol; 2017 Oct; 125(1):101-106. PubMed ID: 28826629
[TBL] [Abstract][Full Text] [Related]
9. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
10. Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.
Carillo V; Cozzarini C; Rancati T; Avuzzi B; Botti A; Borca VC; Cattari G; Civardi F; Esposti CD; Franco P; Girelli G; Maggio A; Muraglia A; Palombarini M; Pierelli A; Pignoli E; Vavassori V; Zeverino M; Valdagni R; Fiorino C
Radiother Oncol; 2014 Apr; 111(1):100-5. PubMed ID: 24631144
[TBL] [Abstract][Full Text] [Related]
11. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
12. Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer.
McCammon R; Rusthoven KE; Kavanagh B; Newell S; Newman F; Raben D
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):413-20. PubMed ID: 19362783
[TBL] [Abstract][Full Text] [Related]
13. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
14. Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy.
Perna L; Alongi F; Fiorino C; Broggi S; Cattaneo Giovanni M; Cozzarini C; Di Muzio N; Calandrino R
Radiother Oncol; 2010 Oct; 97(1):71-5. PubMed ID: 20307910
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation.
Sini C; Fiorino C; Perna L; Noris Chiorda B; Deantoni CL; Bianchi M; Sacco V; Briganti A; Montorsi F; Calandrino R; Di Muzio N; Cozzarini C
Radiother Oncol; 2016 Jan; 118(1):79-84. PubMed ID: 26702990
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of tomotherapy-based simultaneous integrated boost in whole-pelvis radiation for prostate cancer.
You SH; Lee JY; Lee CG
Yonsei Med J; 2015 Mar; 56(2):510-8. PubMed ID: 25684003
[TBL] [Abstract][Full Text] [Related]
17. Postoperative high-dose pelvic radiotherapy for N+ prostate cancer: toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.
Van Praet C; Ost P; Lumen N; De Meerleer G; Vandecasteele K; Villeirs G; Decaestecker K; Fonteyne V
Radiother Oncol; 2013 Nov; 109(2):222-8. PubMed ID: 24016674
[TBL] [Abstract][Full Text] [Related]
18. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
Arcangeli S; Saracino B; Petrongari MG; Gomellini S; Marzi S; Landoni V; Gallucci M; Sperduti I; Arcangeli G
Radiother Oncol; 2007 Aug; 84(2):148-55. PubMed ID: 17692416
[TBL] [Abstract][Full Text] [Related]
19. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
[TBL] [Abstract][Full Text] [Related]
20. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.
D'Avino V; Palma G; Liuzzi R; Conson M; Doria F; Salvatore M; Pacelli R; Cella L
Radiat Oncol; 2015 Apr; 10():80. PubMed ID: 25890376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
